Literature DB >> 31343808

Misdiagnosis of ARVC leading to inappropriate ICD implant and subsequent ICD removal - lessons learned.

Apurva Sharma1, Fabrizio Assis1, Cynthia A James1, Brittney Murray1, Crystal Tichnell1, Harikrishna Tandri1, Hugh Calkins1.   

Abstract

INTRODUCTION: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited progressive cardiomyopathy characterized by frequent life-threatening arrhythmias. The diagnosis of ARVC is challenging and is on the basis of a set of major and minor criteria as described by the modified Task Force Criteria (TFC). We report our clinical experience in a series of patients who were misdiagnosed with ARVC and subsequently underwent removal of their implantable cardioverter defibrillator (ICD) after a re-evaluation at our center. METHODS AND
RESULTS: We studied 12 patients who were misdiagnosed with ARVC and had ICD implantation before our assessment. All patients had a repeat evaluation and were scored according to TFC before ICD removal. Cardiac magnetic resonance imaging (CMR) studies performed at outside institutions during the initial evaluation were reported abnormal and classified as meeting major TFC in ninety percent of patients. The most common abnormality reported was fatty infiltration of the right ventricular (RV) free wall and/or presence of focal intra-myocardial fat in six patients (50%). On re-evaluation, none of these findings fulfilled the TFC for the diagnosis.
CONCLUSION: This study demonstrated that high dependence on misinterpretation of CMR along with a misunderstanding of the TFC evaluation are the main reasons for the misdiagnosis of ARVC. Despite the updated criteria for almost a decade, this study reminds that the diagnosis of ARVC is complex and hence careful TFC evaluation and consideration of multiple cardiac test results should be the focused approach for clinicians when confronted with suspected ARVC patients.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  arrhythmogenic right ventricular cardiomyopathy; cardiac magnetic resonance imaging; electrophysiology study; implantable cardioverter-defibrillator; misdiagnosis

Year:  2019        PMID: 31343808     DOI: 10.1111/jce.14088

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  3 in total

Review 1.  Arrhythmias as Presentation of Genetic Cardiomyopathy.

Authors:  J Lukas Laws; Megan C Lancaster; M Ben Shoemaker; William G Stevenson; Rebecca R Hung; Quinn Wells; D Marshall Brinkley; Sean Hughes; Katherine Anderson; Dan Roden; Lynne W Stevenson
Journal:  Circ Res       Date:  2022-05-26       Impact factor: 23.213

2.  Establishment of a Dedicated Inherited Cardiomyopathy Clinic: From Challenges to Improved Patients' Outcome.

Authors:  Emily Smith; Paul D Thompson; Carolyn Burke-Martindale; Adaya Weissler-Snir
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

3.  A Novel Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Biomarker-Anti-DSG2-Is Absent in Athletes With Right Ventricular Enlargement.

Authors:  David Dorian; Diptendu Chatterjee; Kim A Connelly; Jack M Goodman; Andrew T Yan; Robert F Bentley; Laura Banks; Robert M Hamilton; Paul Dorian
Journal:  CJC Open       Date:  2021-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.